About Iovance (IOVA)
Iovance Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of cell therapies as novel cancer immunotherapy products designed to harness the power of a patient’s own imm... Read more
- USD3.60
- USD3.60
- USD3.32
- USD14.23
- 7.80%
- 164M
- 10.88M
- 9.82M
- 1.2B
- 2.70
- -69.50%
Stock News
2 hours ago
China says ‘door is open’ for trade talks with U.S., sending stock futures higher
MarketWatch
yesterday
Block shares plunge 17% on revenue miss
CNBC
yesterday
The Federal Savings Bank Partners with Blend to Power a Faster Mortgage Refinance Experience for Borrowers
Yahoo
yesterday
Spin purgatory: How DuPont and Honeywell shares have battled ahead of their splits
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
